HIV Prevention Among Vulnerable Male Youth
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01771237|
Recruitment Status : Completed
First Posted : January 18, 2013
Last Update Posted : February 1, 2018
|Condition or disease||Intervention/treatment||Phase|
|Homosexuality, Male HIV Substance-related Disorders Sexual Dysfunctions, Psychological||Behavioral: MyPeeps Manualized Group Intervention Behavioral: Standard Sexual Health Education||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||121 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Feasibility and Acceptability Trial of Behavioral Group-based HIV Prevention Intervention for Young Men Who Have Sex With Men (YMSM).|
|Study Start Date :||July 2007|
|Actual Primary Completion Date :||January 2011|
|Actual Study Completion Date :||January 2011|
Experimental: MyPeeps Manualized Group Intervention
Highly interactive, HIV prevention skills-based group intervention in 6 sessions. Tailored to YMSM.
Behavioral: MyPeeps Manualized Group Intervention
Topics include: HIV/STI transmission, interpersonal communication, stigma management, condom use, substance use and risky sex, HIV-related harm reduction
Other Name: MyPeeps Intervention
Active Comparator: Standard Sexual Health Education
Educational group intervention focused on HIV and STI knowledge using a lecture-based format in 6 sessions. Non-tailored to YMSM.
Behavioral: Standard Sexual Health Education
Topics include: HIV/STI transmission facts, myths regarding HIV transmission, information on effectiveness of condom use
Other Name: Sexual health education-as-usual
- Change in AIDS-risk behavior (AIDS-Risk Behavior Assessment - ARBA) [ Time Frame: Baseline, 6- and 12-week ]The ARBA assesses changes in substance use (i.e, type of drugs, number of times, method), sexual behavior (e.g., frequency of condom use, frequency of sex with high-risk partners, frequency of sex while using drugs or alcohol, number of partners, frequency of vaginal, oral, and anal sex, and age of sexual debut) and lifetime needle use (e.g., any history of tattooing, sharing, and piercing) across three time periods (i.e., 2 weeks preintervention, 6 week postintervention, and 12 week postintervention).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01771237
|United States, Illinois|
|Ann and Robert H. Lurie Children's Hospital of Chicago|
|Chicago, Illinois, United States, 60611|
|Principal Investigator:||Robert Garofalo, MD, MPH||Ann & Robert H Lurie Children's Hospital of Chicago|